Arvinas Inc. (ARVN) Financial Statements (2024 and earlier)

Company Profile

Business Address 395 WINCHESTER AVE
NEW HAVEN, CT 06511
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,261,0001,205,3001,502,600688,531280,873187,828
Cash and cash equivalents311,70081,300108,300588,3739,2113,190
Short-term investments949,3001,124,0001,394,300100,158271,661184,638
Restricted cash and investments5,5005,5004,500   
Receivables7,2008,00025,7008,4446,2815,032
Other undisclosed current assets6,50021,40019,7006,1133,7272,818
Total current assets:1,280,2001,240,2001,552,500703,088290,881195,678
Noncurrent Assets
Operating lease, right-of-use asset2,5004,4003,9001,9932,279
Property, plant and equipment11,50013,40012,70012,2608,4553,583
Deposits noncurrent assets      21
Other noncurrent assets    2927 
Other undisclosed noncurrent assets10,40010,80012,500   
Total noncurrent assets:24,40028,60029,10014,28110,7613,604
TOTAL ASSETS:1,304,6001,268,8001,581,600717,369301,641199,282
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:92,20074,70054,40025,98212,1606,759
Accounts payable17,8005,70031,3007,1224,5572,758
Accrued liabilities28,90033,10023,10018,8607,6034,001
Other undisclosed accounts payable and accrued liabilities45,50035,900    
Deferred revenue163,000218,600206,20022,15119,980
Debt200   674154
Contract with customer, liability16,066
Other undisclosed current liabilities1,7001,8001,100953  
Total current liabilities:257,100295,100261,70049,08532,81322,980
Noncurrent Liabilities
Long-term debt and lease obligation8001,0003,9003,0873,7142,000
Long-term debt, excluding current maturities8001,0001,0002,0002,0002,000
Liabilities, other than long-term debt386,700407,800534,30022,93838,42837,635
Deferred revenue386,200405,100534,30022,93838,428
Contract with customer, liability37,485
Other liabilities      150
Operating lease, liability5002,7002,9001,0871,714
Total noncurrent liabilities:387,500408,800538,20026,02642,14239,635
Total liabilities:644,600703,900799,90075,11174,95562,615
Equity
Equity, attributable to parent660,000564,900781,700642,258226,686136,667
Common stock100100 483831
Additional paid in capital1,995,7001,549,4001,469,2001,133,537599,097439,118
Accumulated other comprehensive income (loss)(3,100)(19,200)(4,600)561108(218)
Accumulated deficit(1,332,700)(965,400)(682,900)(491,889)(372,557)(302,265)
Total equity:660,000564,900781,700642,258226,686136,667
TOTAL LIABILITIES AND EQUITY:1,304,6001,268,8001,581,600717,369301,641199,282

Income Statement (P&L) ($ in thousands)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues78,500131,40046,70021,80242,97614,324
Gross profit:78,500131,40046,70021,80242,97614,324
Operating expenses(480,000)(394,600)(242,000)(146,659)(94,501)(58,126)
Operating loss:(401,500)(263,200)(195,300)(124,857)(51,525)(43,802)
Nonoperating income37,60012,2004,3005,5255,9072,322
Investment income, nonoperating38,80012,0001,9003,5864,5572,470
Other nonoperating income (expense)(1,200)2002,5002,0051,436103
Interest and debt expense   (100)(65)(86)(57)
Loss from continuing operations before equity method investments, income taxes:(363,900)(251,000)(191,100)(119,397)(45,703)(41,538)
Loss from equity method investments(2,500)(10,600)  (24,675) 
Loss from continuing operations before income taxes:(366,400)(261,600)(191,100)(119,397)(70,378)(41,538)
Income tax expense(900)(20,900)    
Loss from continuing operations:(367,300)(282,500)(191,100)(119,397)(70,378)(41,538)
Loss before gain (loss) on sale of properties:(191,100)(119,397)(70,378)(41,538)
Other undisclosed net income   100658657
Net loss attributable to parent:(367,300)(282,500)(191,000)(119,332)(70,292)(41,480)
Preferred stock dividends and other adjustments      (198,367)
Net loss available to common stockholders, diluted:(367,300)(282,500)(191,000)(119,332)(70,292)(239,847)

Comprehensive Income ($ in thousands)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(367,300)(282,500)(191,000)(119,332)(70,292)(41,480)
Comprehensive loss:(367,300)(282,500)(191,000)(119,332)(70,292)(41,480)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent16,100(14,500)(5,200)453325(208)
Comprehensive loss, net of tax, attributable to parent:(351,200)(297,000)(196,200)(118,879)(69,967)(41,688)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: